Summary
Aware reported fourth-quarter revenue of $4.06 million, up 1.7% from the prior-year quarter. Full-year revenue was $16.01 million, down 5.0% from the prior year. The quarterly operating loss was $2.02 million, and the loss widened from the prior-year quarter. For the full year, the operating loss narrowed to $2.22 million. Operating margin was -49.7% in the quarter, down 11.6 percentage points from the prior-year quarter, while the full-year operating margin improved to -13.8%, up 22.3 percentage points. The full-year improvement came despite lower revenue. Management attributes it primarily to the gain on the sale of the corporate office, partly offset by lower revenue and higher selling and marketing and general and administrative expenses. The revenue decline was driven by lower perpetual software license sales and lower services and other revenue, partly offset by higher software maintenance and subscription-based license revenue.
Net loss for the fourth quarter was $1.76 million, and the loss widened from the prior-year quarter. Full-year net loss narrowed to $1.73 million, and diluted EPS improved to -$0.08 for the full year from the prior year. Deferred revenue was $3.73 million at December 31, 2022, essentially flat from the prior-year quarter. Operating cash flow was negative $0.48 million in the quarter, up 52.7% from the prior-year quarter, and negative $5.04 million for the full year, up 19.1%. Capital expenditures were $0.59 million in the quarter, up from a very small amount in the prior-year quarter, and $0.73 million for the full year, up from a very small amount in the prior year. The company reports capital expenditures as a cash outflow shown as a positive amount. Selling and marketing expense rose on severance costs tied to the termination of the Chief Commercial Officer position in August 2022 and on marketing promotions. General and administrative expense rose on higher bad debt expense.
Aware sells biometrics products, solutions, and services for government and commercial systems. Government uses include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Commercial uses include user enrollment and authentication for login to devices, networks, and software, financial transactions, physical access control, and identity proofing. The company sells through systems integrators, OEMs, VARs, partners, and directly to end users. It also licenses imaging software to OEMs and systems integrators for medical imaging products and systems. Engineering headcount decreased from 49 in 2021 to 46 in 2022, and management believes the engineering organization was adequately staffed at December 31, 2022. The company recognizes revenue from its AwareID hosted environment ratably over the subscription period. The company sold its corporate headquarters in Bedford, MA in July 2022.
Management's forward-looking commentary points to higher absolute research and development and general and administrative spending, with both expected to fall as a percentage of revenue, and to an expanded sales and marketing force. The company intends to introduce new products to offer more complete biometrics solutions and may purchase or license technologies from third parties if internal development is not possible. The 10-K does not provide a numeric revenue or earnings outlook for the next quarter or the full fiscal year. Known contractual cash requirements include operating lease payments estimated at approximately $0.5 million in 2023 and $0.7 million in each of 2024, 2025, 2026, and 2027, plus $4.2 million thereafter. Management states that cash, cash equivalents, and marketable securities are sufficient to fund operations for at least the next twelve months from the filing date. Risks include dependence on winning biometrics systems projects, fluctuating services gross margins, potential impairment of goodwill and intangible assets, a full valuation allowance against deferred tax assets, doubtful account provisions, and inflation. The company also says it may need additional financing if future growth or investment needs require it. It has no off-balance sheet arrangements with unconsolidated entities. It notes that inflation has not had a material impact on financial results to date but could adversely affect future results.
Forecast
Reported figures
GAAP, from SEC filings| Metric | Q4 FY2022 | Q3 FY2022 | QoQ | Q4 FY2021 | YoY |
|---|---|---|---|---|---|
| Revenue | $4.1M | $3.0M | +34.8% | $4.0M | +1.7% |
| Gross profit | $3.7M | $2.7M | +36.2% | $3.7M | +0.1% |
| Gross margin | 91.6% | 90.7% | +1.0 pp | 93.1% | -1.4 pp |
| Research & development | $2.3M | $2.3M | +1.0% | $2.2M | +5.0% |
| Sales & marketing | $1.9M | $1.9M | +1.1% | $1.5M | +23.1% |
| General & administrative | $1.5M | $1.8M | -14.5% | $1.5M | +2.1% |
| Total operating expenses | $6.1M | $571.0K | +965.3% | $5.5M | +10.2% |
| Operating income (loss) | -$2.0M | $2.4M | -182.7% | -$1.5M | -32.5% |
| Operating margin | -49.7% | 81.1% | -130.8 pp | -38.1% | -11.6 pp |
| Net income (loss) | -$1.8M | $2.6M | -167.6% | -$1.3M | -40.0% |
| Net margin | -43.2% | 86.2% | -129.4 pp | -31.4% | -11.8 pp |
| Diluted EPS | -$0.08 | $0.12 | -$0.20 | -$0.06 | -$0.02 |
Risks
The company derives a significant portion of revenue directly or indirectly from federal, international, state and local governments. Changes in government contracting policies, fiscal constraints, funding priorities, appropriations delays, or invoice payment delays could reduce purchases and materially affect results.
The company warns individual orders can represent a meaningful percentage of revenues and their timing is difficult to predict; failure to close, deferral, or cancellation can cause quarterly revenue and net income shortfalls. Because operating costs are largely fixed, even a small revenue shortfall can disproportionately hurt quarterly results.
The company derives a significant portion of revenue from third-party channel partners, including systems integrators, VARs, and OEMs, and their activities are not within direct control. A reduction in partner sales efforts, failure to win government awards, misalignment, or termination of a major systems integrator or OEM could materially harm results.
MD&A reports services and other revenue decreased 31% from $2.2 million in 2021 to $1.5 million in 2022, while cost of services and other as a percentage of that revenue increased from 55% to 83%, causing services gross margins to decrease from 45% to 17%. This margin deterioration may continue based on project mix, complexity, and pricing.
MD&A attributes the lower FY2022 operating loss primarily to a $5.7 million gain on the sale of the former corporate headquarters, partially offset by a $0.8 million revenue decrease and higher selling and marketing and general and administrative expenses. This improvement may not be sustainable because the gain is non-recurring, and the current quarter operating loss widened 32.5% versus the prior-year quarter.
The biometrics market faces intense competition from diversified providers such as Idemia, Thales, and NEC and component providers such as FaceTec, iProov, and Innovatrics. Many competitors have greater financial, marketing, and research resources, and low-cost foreign competitors may pressure prices.
A significant commercial market for biometrics technology may not develop or may develop slowly, and traditional security methods still compete. If biometrics solutions generally or the company's solutions do not gain broad market acceptance, growth and revenue could be adversely affected.
The biometrics industry is characterized by rapid technological change and evolving standards, requiring difficult bets on future technology direction. Delays, wrong technical choices, or failure to offer innovative products at competitive prices could cause customers to buy competitors' products.
Adverse economic conditions, including recessions, inflation, turmoil in financial markets, the Russia-Ukraine conflict and related sanctions, and rising interest rates, could reduce demand, increase order cancellations or delays, pressure prices, and make collections harder. MD&A states inflation has not had a material impact to date, but no assurance is given that it will not adversely affect future results.
Extensive federal, state, and foreign privacy and data protection laws govern biometric data, including GDPR, CPRA, Illinois Biometric Privacy Act, Texas biometric statute, Washington H.B. 1493, and Brazil's LGPD. Compliance costs, fines, or penalties could materially affect results.
The company completed acquisitions of FortressID in December 2021 and AFIX in November 2020, and integration is complex, costly, and time-consuming. Contingent acquisition payments can restrict integration and lead to disputes or litigation, and acquisitions may negatively impact net income and EPS; goodwill was $3.1 million and intangibles $2.8 million at December 31, 2022.
The company relies on key personnel and employment relationships are at-will, with past departures noted. MD&A reports engineering headcount decreased slightly from 49 in 2021 to 46 in 2022 and selling and marketing expense included $0.3 million of severance costs related to terminating the Chief Commercial Officer position in August 2022.
General and administrative expense increased 5% from $6.2 million in 2021 to $6.4 million in 2022, primarily due to bad debt expense increases of $0.4 million. If collection judgments do not reflect future ability to collect, additional doubtful account provisions may be required.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q4 FY2022 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Oct 2, 2026.